Acquired Myopathy/Dystrophies
dc.contributor.author | Chiodo, Anthony | |
dc.date.accessioned | 2019-01-15T20:29:37Z | |
dc.date.available | 2019-01-15T20:29:37Z | |
dc.date.issued | 2013-05 | |
dc.identifier.citation | Chiodo, Anthony (2013). "Acquired Myopathy/Dystrophies." PM&R 5: S74-S80. | |
dc.identifier.issn | 1934-1482 | |
dc.identifier.issn | 1934-1563 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/147092 | |
dc.description.abstract | Diseases of muscle may be congenital or acquired. They cause muscle weakness without sensory loss. The onset, distribution, and clinical course help to differentiate the type of muscle disorder. The diagnostic workup may include laboratory examination, electrodiagnostic studies, and muscle biopsy. A definitive diagnosis leads to better decision making with regard to treatment, genetic education, prognosis, functional expectations, and the impact of exercise on muscle function. | |
dc.publisher | Wiley Periodicals, Inc. | |
dc.title | Acquired Myopathy/Dystrophies | |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Kinesiology and Sports | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.description.peerreviewed | Peer Reviewed | |
dc.contributor.affiliationum | Physical Medicine and Rehabilitation, University of Michigan Hospital, 325 E Eisenhower Parkway, Ann Arbor, MI 48118 | |
dc.description.bitstreamurl | https://deepblue.lib.umich.edu/bitstream/2027.42/147092/1/pmr2s74.pdf | |
dc.identifier.doi | 10.1016/j.pmrj.2013.04.004 | |
dc.identifier.source | PM&R | |
dc.identifier.citedreference | J. Chang, Y.G. Park, Y.C. Choi, J.H. Choi, J.H. Moon. Correlation of electromyogram and muscle biopsy in myopathy of young age. Arch Phys Med Rehabil. 2011; 92: 780 – 784. | |
dc.identifier.citedreference | S. Rayavarapu, W. Coley, K. Nagaraju. An update on pathogenic mechanisms of inflammatory myopathies. Curr Opin Rheumatol. 2011; 23: 579 – 584. | |
dc.identifier.citedreference | M.H. Maeda, S. Tsuji, J. Shimizu. Inflammatory myopathies associated with anti‐mitochondrial antibodies. Brain. 2012; 135: 1767 – 1777. | |
dc.identifier.citedreference | G.A. Quiceno, J.J. Cush. Iatrogenic rheumatic syndromes in the elderly. Rheum Dis Clin North Am. 2007; 33: 123 – 134. | |
dc.identifier.citedreference | F.L. Mastaglia. Iatrogenic myopathies. Curr Opin Neurol. 2010; 23: 445 – 449. | |
dc.identifier.citedreference | A.L. Mammen, A.A. Amato. Statin myopathy: A review of recent progress. Curr Opin Rheumatol. 2010; 22: 644 – 650. | |
dc.identifier.citedreference | D.R. Thomas. Sarcopenia. Clin Geriatric Med. 2010; 26: 331 – 346. | |
dc.identifier.citedreference | J. Hernandez‐Rodriguez, M.S. Cid, A. Lopez‐Soto, G. Espigol‐Frigole, X. Bosch. Treatment of polymyalgia rheumatic. Arch Intern Med. 2009; 169: 1839 – 1844. | |
dc.identifier.citedreference | C. Salvarani, F. Cantini, G.G. Hunder. Polymyalgia rheumatica and giant‐cell arteritis. Lancet. 2008; 372: 234 – 245. | |
dc.identifier.citedreference | M. Mancuso, S. Piazza, L. Volpi, et al. Nerve and muscle involvement in mitochondrial disorders: An electrophysiolocal study. Neurol Sci. 2012; 33: 449 – 452. | |
dc.identifier.citedreference | J. Finsterer, W. Strobl. Orthopaedic abnormalities in primary myopathies. Acta Orthop Belg. 2011; 77: 563 – 582. | |
dc.identifier.citedreference | R. Quinlivan, J. Vissing, D. Hilton‐Jones, J. Buckley. Physical training for McArdle disease. Cochrane Database Syst Rev. 2011; (12), CD007931. | |
dc.identifier.citedreference | H. Alexanderson. Exercise effects in patients with adult idiopathic inflammatory myopathies. Curr Opin Rheumal. 2009; 21: 158 – 163. | |
dc.identifier.citedreference | G.E.A. Habers, T. Takken. Safety and efficacy of exercise training in patients with idiopathic inflammatory myopathy: A systematic review. Rheumatology. 2011; 50: 2113 – 2124. | |
dc.identifier.citedreference | M.A. Tarnopolsky. Creatine as a therapeutic strategy for myopathies. Amino Acids. 2011; 40: 1397 – 1407. | |
dc.identifier.citedreference | T.A. Rando. The dystrophin‐glycoprotein complex, cellular signaling, and the regulation of cell survival in the muscular dystrophies. Muscle Nerve. 2001; 24: 1575 – 1594. | |
dc.identifier.citedreference | F. Barthelemy, N. Wein, M. Krahn, N. Levy, M. Bartoli. Translational research and therapeutic perspectives in dysferlinopathies. Mol Med. 2011; 17: 875 – 882. | |
dc.identifier.citedreference | Z.Z. Tang, V. Yarotskyy, L. Wei, et al. Muscle weakness in myotonic dystrophy associated with misregulated splicing and altered gating of Ca(V)1.1 calcium channel. Hum Mol Genet. 2012; 21: 1312 – 1324. | |
dc.identifier.citedreference | D. Selcen, M.B. Bromberg, S.S. Chin, A.G. Engel. Reducing bodies and myofibrillar myopathy features in FHL1 muscular dystrophy. Neurology. 2011; 77: 1951 – 1959. | |
dc.identifier.citedreference | L. Brinas, P. Richard, S. Quijano‐Roy, C. Gartious. Early onset collagen VI myopathies: Genetic and clinical correlations. Ann Neurol. 2010; 68: 511 – 520. | |
dc.identifier.citedreference | J.R. Nance, J.J. Dowling, E.M. Gibbs, C.G. Bonnemann. Congenital myopathies: An update. Curr Neurol Neurosci Rep. 2012; 12: 165 – 174. | |
dc.identifier.citedreference | M. Scoto, S. Cirak, R. Mein, L. Feng, et al. SEPN1‐related myopathies. Neurology. 2011; 76: 2073 – 2078. | |
dc.identifier.citedreference | N.F. Clarke. Congenital fiber‐type disproportion. Semin Pediatr Neurol. 2011; 18: 264 – 271. | |
dc.identifier.citedreference | L. Volpi, G. Ricci, D. Orsucci, et al. Metabolic myopathies: Functional evaluation by different exercise testing approaches. Musculoskelet Surg. 2011; 95: 59 – 67. | |
dc.identifier.citedreference | B.J. Byrne, D.J. Falk, C.A. Pacak, et al. Pompe disease gene therapy. Hum Mol Genet. 2011; 20: R61 – R68. | |
dc.identifier.citedreference | A. Hassani, R. Horvath, P.F. Chinnery. Mitochondrial myopathies: Developments in treatment. Curr Opin Neurol. 2010; 23: 459 – 465. | |
dc.identifier.citedreference | S. Cox, V. Limaye, C. Hill, P. Blumbergs, P. Roberts‐Thomson. Idiopathic inflammatory myopathies: Diagnostic criteria, classification and epidemiological features. Int J Rheum Dis. 2010; 13: 117 – 124. | |
dc.identifier.citedreference | O. Benveniste, D. Hilton‐Jones. International Workshop on Inclusion Body Myositis held at the Institute of Myology, Paris, on 29 May 2009. Neuromuscul Disord. 2010; 20: 414 – 421. | |
dc.identifier.citedreference | A. Echaniz‐Laguna, M. Mohr, B. Lannes, C. Tranchant. Myopathies in the elderly: A hospital based study. Neuromuscul Disord. 2010; 10: 443 – 447. | |
dc.identifier.citedreference | A. Pestronk. Acquired immune and inflammatory myopathies: Pathologic classification. Curr Opin Rheumatol. 2011; 23: 595 – 604. | |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe its collections in a way that respects the people and communities who create, use, and are represented in them. We encourage you to Contact Us anonymously if you encounter harmful or problematic language in catalog records or finding aids. More information about our policies and practices is available at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.